A Revolutionary Step Toward Ending the HIV Epidemic

Lenacapavir, a twice-yearly injectable medication, stands out as my final article of 2024, highlighting one of the most remarkable advancements in HIV prevention this year. With up to 100% efficacy in trials, it offers new hope for ending the epidemic. Ensuring global access remains important to its transformative potential.